Combination of cyclosporine and splene-ctomy suppresses interleukin-6 production and major histocompatibility complex class II expression and prolongs cardiac xenograft survival

Journal of Thoracic and Cardiovascular Surgery

Volumn 107, Issue 4, 1994, Pages 1001-1005

  Peterson, Steven M ^a   Strzalka, Christopher T ^a   Johnkoski, John A ^a   Noble, Bernice ^b   Gorfien, Janet ^b   Hoover, Eddie L ^a   Bergsland, Jacob ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMORAL IMMUNITY; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLENECTOMY; SYRIAN HAMSTER; XENOGRAFT;

ANIMAL; ANTIBODY FORMATION; CYCLOSPORINE; GRAFT SURVIVAL; HAMSTERS; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; INTERLEUKIN-6; MALE; MESOCRICETUS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SPLENECTOMY; SUPPORT, U.S. GOV'T, NON-P.H.S.; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0028279113     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(94)70374-4     Document Type: Article

References (16)

1. Hamster-to-rat cardiac xenografts: a useful model for transplantation studies
2. Evidence that deoxyspergualine prevents sensitization and first-set cardiac Yenograft rejection in rats by suppression of antibody formation
3. Both concordant and discordant heart xenografts are rejected by athymic (nude) rats with the same tempo as is T cell competent animals
4. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas
5. B-cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes
6. Evidence that production of interleukin 6 within the rejecting allograft coincides with cytotoxic T lymphocyte development
7. Accessory factors involved in murine T cell activation: distinct roles of IL-6, IL-1 and TNF
8. Differential in situ expression of cytokines in renal allograft rejection
9. Biliary interleukin 6 levels as indicators of hepatic allograft rejection in rats
10. Improved technique of heart transplantation in rats
11. An important role of the spleen in rejection of hamster-to-rat xenografts
12. Role of splenectomy as adjunctive therapy in suppressing cardiac xenograft humoral immunity
13. A crucial effect of splenectomy on prolonging cardiac xenograft survival in combination with cyclosporine
14. Activation of endothelial cells in hyperacute xenograft rejection
15. The role of antiendothelial antibody in primate cardiac xenograft rejection
16. Endothelial cell proteoglycans in xenotransplantation